-
University of Massachusetts et al v. L'Oreal U.S.A., Inc. DC CAFC
- 1:17-cv-00868
- D. Del.
- Judge: Jennifer L. Hall +1
- Filed: 06/30/2017
- Closed: 04/15/2024
- Latest Docket Entry: 04/15/2024
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
2
Patents-in-Suit
2,482
Days in
Litigation
-
University of Massachusetts et al v. L'Oreal U.S.A., Inc. DC CAFC
- 1:17-cv-00868
- D. Del.
- Judge: Jennifer L. Hall +1
- Filed: 06/30/2017
- Closed: 04/15/2024
- Latest Docket Entry: 04/15/2024
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for enhancing the condition of unbroken skin of a mammal by reducing one or more of wrinkling, roughness, dryness, or laxity of the skin, without increasing dermal cell proliferation, the method comprising topically applying to the skin a
view more
|
Invalid
Entry 414 Entry 411 |
3 |
The method of claim 1, wherein the adenosine concentration is 10<HIL><SP>−1 </SP></HIL>M to 10<HIL><SP>−6 </SP></HIL>M.
|
Invalid
Entry 414 Entry 411 |
5 |
The method of claim 1, wherein the composition further comprises a conditioning agent.
|
Invalid
Entry 414 Entry 411 |
6 |
The method of claim 5, wherein the conditioning agent is a humectant, an emollient, or an occlusive agent.
|
Invalid
Entry 414 Entry 411 |
7 |
The method of claim 6, wherein the mammal is a human.
|
Invalid
Entry 414 Entry 411 |
9 |
The method of claim 1, wherein the composition further comprises a transdermal delivery agent.
|
Invalid
Entry 414 Entry 411 |
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for enhancing the condition of unbroken skin of a mammal by reducing one or more of wrinkling, roughness, dryness, or laxity of the skin, without increasing dermal cell proliferation, the method comprising topically applying to the skin a
view more
|
Invalid
Entry 414 Entry 411 |
3 |
The method of claim 1, wherein the adenosine concentration is 10<HIL><SP>−4 </SP></HIL>M to 10<HIL><SP>−6 </SP></HIL>M.
|
Invalid
Entry 414 Entry 411 |
5 |
The method of claim 1, wherein the composition further comprises a conditioning agent.
|
Invalid
Entry 414 Entry 411 |
6 |
The method of claim 5, wherein the conditioning agent is a humectant, an emollient, or an occlusive agent.
|
Invalid
Entry 414 Entry 411 |
7 |
The method of claim 1, wherein the mammal is a human.
|
Invalid
Entry 414 Entry 411 |
9 |
The method of claim 1, wherein the composition further comprises a transdermal delivery agent.
|
Invalid
Entry 414 Entry 411 |